EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials

Raj Sengupta, Pedro M Machado, Philippe Goupille, Martin Rudwaleit, Mohamed Sheesh, Khai Jing Ng, Marcus Ngantcha, Yan Yan, Hagen Russ, Gabriel Doridot, Yu Xue, Denis Poddubnyy und 2 weitere

Rheumatology and Therapy · 2026-08 · 13 (4) · 1107-1124

DOI: 10.1007/s40744-026-00862-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology and Therapy, online erschienen am 02.06.2026. Verfasst von Raj Sengupta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology, Royal National Hospital for Rheumatic Diseases NHS, Upper Borough Walls, Bath, BA11RL, UK. rajsen99@gmail.com. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Axial spondyloarthritisBiologic disease-modifying antirheumatic drugC-reactive proteinInterleukin-17A inhibitor

Autor:innen und Institutionen

  • Rheumatology, Royal National Hospital for Rheumatic Diseases NHS, Upper Borough Walls, Bath, BA11RL, UK. rajsen99@gmail.com.
  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • National Institute for Health Research (NIHR), University College London Hospitals Biomedical Research Centre, London, UK.
  • Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.
  • UPR CNRS 4301 CBM, NMNS, University of Tours, Tours, France.
  • Department of Rheumatology, University Hospital, Tours, France.

Förderung

  • Eli Lilly and Company

Zitieren

APA

Sengupta, R., Machado, P. M., Goupille, P., Rudwaleit, M., Sheesh, M., Ng, K. J., Ngantcha, M., Yan, Y., Russ, H., Doridot, G., Xue, Y., Poddubnyy, D., Baraliakos, X., & Navarro-Compán, V. (2026). Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials. Rheumatology and Therapy, 13(4), 1107-1124. https://doi.org/10.1007/s40744-026-00862-1

Vancouver

Sengupta R, Machado PM, Goupille P, Rudwaleit M, Sheesh M, Ng KJ, et al. Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials. Rheumatology and Therapy. 2026;13(4):1107-1124. doi:10.1007/s40744-026-00862-1

BibTeX
@article{Sengupta2026,
  author = {Sengupta, Raj and Machado, Pedro M and Goupille, Philippe and Rudwaleit, Martin and Sheesh, Mohamed and Ng, Khai Jing and Ngantcha, Marcus and Yan, Yan and Russ, Hagen and Doridot, Gabriel and Xue, Yu and Poddubnyy, Denis and Baraliakos, Xenofon and Navarro-Compán, Victoria},
  title = {Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials},
  journal = {Rheumatology and Therapy},
  year = {2026},
  volume = {13},
  number = {4},
  pages = {1107--1124},
  doi = {10.1007/s40744-026-00862-1}
}
Kostenlos starten →